Overexpression of ACE in myelomonocytes substantially reduced Aβ load and prevented Alzheimer’s disease-like cognitive decline in mice (Bernstein et al., 2014). This evidence concerns the gene ACE and early-onset autosomal dominant Alzheimer disease.